Enhance Skin Products Inc (EHSK)

Ticker: EHSK


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Botnevik Frode Non-Executive Director
Transaction date
Purchase
Price
352.30
Quantity 23,290 +16.5%
Value US$4,281,497
Biostrategies Consulting Group Inc Large shareholder
Transaction date
Sale
Price
444.83
Quantity 67,132 +15.5%
Value US$2,867,101
Asculai Samuel CEO Executive Director Large shareholder
Transaction date
Purchase
Price
224.83
Quantity 28,830 +18.4%
Value US$2,961,167
Biostrategies Consulting Group Inc Large shareholder
Transaction date
Sale
Price
0.01
Quantity 9,166,666 -33.3%
Value US$91,667
Asculai Samuel CEO Executive Director Large shareholder
Transaction date
Sale
Price
0.01
Quantity 9,166,666 -34.4%
Value US$91,667
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2013-07-24 2013-07-22 B Purchase Botnevik Frode Non-Executive Director
23,290 +16.5%
352.30
US$4,281,497
23,290 +16.5% 352.30 US$4,281,497
2010-08-19 2010-05-12 S Sale Biostrategies Consulting Group Inc Large shareholder
67,132 +15.5%
444.83
US$2,867,101
67,132 +15.5% 444.83 US$2,867,101
2010-08-19 2010-05-12 B Purchase Asculai Samuel

CEO

Executive Director Large shareholder
28,830 +18.4%
224.83
US$2,961,167
28,830 +18.4% 224.83 US$2,961,167
2010-08-19 2010-05-12 S Sale Biostrategies Consulting Group Inc Large shareholder
9,166,666 -33.3%
0.01
US$91,667
9,166,666 -33.3% 0.01 US$91,667
2010-08-19 2010-05-12 S Sale Asculai Samuel

CEO

Executive Director Large shareholder
9,166,666 -34.4%
0.01
US$91,667
9,166,666 -34.4% 0.01 US$91,667
Explore more

More insider trading research around Enhance Skin Products Inc